Insider · CIK 0001034608
Michael S Gordon
Files at PMN (ProMIS Neurosciences Inc.). First filing -, latest -.
In brief
Michael S Gordon files SEC Form 4 as 10% owner at PMN (ProMIS Neurosciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael S Gordon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Mar 13, 2025 | PMN ProMIS Neurosciences Inc. | JOther Common Shares, no par valueindirect: By Title 19 Acies | -48,333 | - | - | 0 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,195,429 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,315,229 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,435,029 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 29, 2025 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Warrants to Purchase Common Sharesderivativeindirect: See footnote | +539,100 | - | - | 539,100 | Jul 29, 2025 |
| Jun 30, 2025 | PMN ProMIS Neurosciences Inc. | SOpen-market sale Common Shares, no par value | -93,223 | - | - | 0 | Jul 2, 2025 |
Questions about Michael S Gordon
Answered from the filings on this page, as of the latest one.
Is Michael S Gordon buying or selling?
Michael S Gordon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael S Gordon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael S Gordon has 0.
Where does Michael S Gordon file Form 4?
Michael S Gordon has filed Form 4 at PMN (ProMIS Neurosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.